| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $748.0M | +40.8% |
| Cost of Revenue | $203.6M | +43.3% |
| Gross Profit | $544.4M | +39.9% |
| R&D Expense | $235.3M | +21.1% |
| SG&A Expense | $156.0M | +18.1% |
| Operating Income | $62.6M | +572.1% |
| Pre-tax Income | $102.3M | +475.5% |
| Income Tax | $13.7M | +703.0% |
| Net Income | $88.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $785.8M | +5.1% |
| Accounts Receivable | $128.9M | +44.9% |
| Current Assets | $1.10B | +22.7% |
| Total Assets | $1.30B | +36.5% |
| Current Liabilities | $422.2M | +52.2% |
| Total Liabilities | $477.2M | +59.9% |
| Stockholders' Equity | $824.5M | +25.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $285.5M | +85.9% |
| Capital Expenditures | $12.1M | +279.7% |
| Investing Cash Flow | -$217.3M | -1499.9% |
| Financing Cash Flow | -$30.0M | -1505.2% |
| Free Cash Flow | $273.4M | +81.8% |
| +451.3% |
| EPS (Basic) | $2.04 | +423.1% |
| EPS (Diluted) | $1.88 | +437.1% |